Aminotetralin derivative for the therapy of cardiovascular diseases
AssigneeChiesi Farmaceutici S.p.A.
InventorsStefano Bongrani, Roberta Razzetti, Maurizio Civelli, Alberto Umile, Paolo Chiesi
Life of this patent
Estimating the term…
Abstract
Left ventricular dysfunction is treated by a process, comprising: administering to a subject suffering from left ventricular remodeling a therapeutically effective amount of 5,6-dihydroxy-2-methylaminotetralin, or 5,6-diisobutyroyl-oxy-2-methyl-aminotetralin, or a pharmaceutically acceptable salt thereof in combination with an angiotensin-converting enzyme inhibitor.
Claims3
The use of 5,6-dihydroxy-2-methylaminotetralin, or 5,6-diisobutyroyloxy-2-methyl-aminotetralin, or a pharmaceutically acceptable salt thereof in combination with an angiotensin-converting enzyme inhibitor for the preparation of a medicament for treating left ventricular dysfunction or remodeling.
Dependencies are inferred from the claim text.